-
Vice President, Clinical Development…
- J&J Family of Companies (Spring House, PA)
-
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com
Job Function:
Discovery & Pre-Clinical/Clinical Development
Job Sub** **Function:
Clinical Development & Research – MD
Job Category:
People Leader
All Job Posting Locations:
Spring House, Pennsylvania, United States of America
Job Description:
Johnson & Johnson is currently seeking a Vice President, Clinical Development – Rheumatology, Rare and Maternal Fetal Immunology (MFI) to join our Late Stage Clinical Development team located in Spring House, PA.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/ .
This position works with the Head of Clinical Development (CD) and Head, Early Development (ED), to refine the vision, mission and strategic objectives of drug development. As a member of the Development Leadership Team, contributes to Immunology Development functional organization by managing the talent strategy, operational excellence and efficiency, and drive key innovation initiatives.
The VP Clinical Development, Rheumatology, Rare & MFI is accountable for the design, implementation and reporting of all Late-stage Phase II and III relevant therapy area clinical trials development in Janssen’s Immunology portfolio. Candidates should have the ability to adapt their therapy area knowledge and expertise to lead and advise on immuno-inflammatory indications based on the needs of the portfolio. The successful candidate will have exceptional clinical development, functional-leadership and communications skills as well as a high degree of curiosity, innovation, entrepreneurship and a keen sense of patient unmet need.
Responsibilities will include: contribution to the Immunology Therapeutic Area (TA) strategy and governance bodies, accountability for program reviews in the broader Janssen R&D structure, and overall strategy and execution for all therapy area relevant late-stage clinical development programs through product licensing. This role also has substantial responsible for defining Late Stage Development approaches for licensing/Business Development activities.
In addition the role incorporates leadership of a team of physicians who design, implement and report all late-stage phase II and III Immunology clinical trials. Overall accountability for delivery of regulatory submissions, including oversight of the preparation of clinical portions of agency licensing applications and other regulatory submissions.
The ability to collaborate will be a key skill. Important partnership include the Disease Area Strongholds (DASs), Pathway Strongholds (PASs), Discovery, Clinical Pharmacology, Medical Affairs and Commercial, and Business Development to deliver all Rheumatology late stage development matters and identify external opportunities and platforms required for next generation Immunology products.
The role will deliver innovative, fit-for-purpose and transformational development strategies that address high unmet needs for all Rheumatology assets in late phase clinical development. This includes next-generation combination regimens to achieve transformative levels of efficacy.
The role will develop and maintain a strong external network including credible relationships with scientific leaders, key clinical opinion leaders, and regulatory officials as needed to advance the Immunology portfolio.
Qualifications - External
EDUCATION AND EXPERIENCE
Education:
MD, or MD/PhD is ideal. Immunology or Rheumatology are preferred areas of expertise.
Experience:
Relevant experience in drug development or equivalent.
Required Knowledge and skills:
+ Outstanding visionary, strategic, communication and entrepreneurial skills
+ The ability to inspire and lead a truly empowered team.
+ Strong capacity to work, collaborate, communicate, influence, and lead in a cross-functional matrix environment, delivering Immunology TA strategies with a one-team, one-portfolio mindset
+ Strong passion to drive programs into diverse indications, based on scientific rationale and unmet medical needs
+ Candidates should possess significant experience in clinical application of approaches to the treatment of immune diseases and a strong passion to drive programs into diverse indications, based on scientific rationale and unmet medical needs
+ Exceptional communication skills and leadership experience in drug discovery and/or early development to communicate goals and deliverables to senior management and governance committees through J&J
Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
\#ImpactImm
-
Recent Jobs
-
Vice President, Clinical Development - Rheumatology, Rare and Maternal Fetal Immunology (MFI)
- J&J Family of Companies (Spring House, PA)